Evidence map›Paper›PMID 31151468›Full record

ArticleOrphanet journal of rare diseases2019

Molecular investigation, using chromosomal microarray and whole exome sequencing, of six patients affected by Williams Beuren syndrome and Autism Spectrum Disorder.

Julie Masson, Caroline Demily, Nicolas Chatron, Audrey Labalme, Pierre-Antoine Rollat-Farnier, Caroline Schluth-Bolard, Brigitte Gilbert-Dussardier, Fabienne Giuliano, Renaud Touraine, Sylvie Tordjman and 6 more

Registry-linked trialOpen access · goldAbstract readLetter
In one paragraph

Article in Orphanet journal of rare diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04095585 (Molecular Investigation, Using Chromosomal Microarray and Whole Exome Sequencing, of Patients Affected by Williams Beuren Syndrome and Autism Spectrum Disorder), which is not on this map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04095585 completednot on this map

Molecular Investigation, Using Chromosomal Microarray and Whole Exome Sequencing, of Patients Affected by Williams Beuren Syndrome and Autism Spectrum Disorder

TypeobservationalSponsorHospices Civils de LyonRan2014 to 2015Enrolled6ConditionsWilliams Beuren Syndrome, Autism Spectrum DisorderArmschromosomal microarray analysis (CMA) and whole exome sequencing (WES)
3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 8 institutions in 2 countries.

Julie MassonService de Génétique, Centre de Référence Anomalies du Développement, Hospices Civils de Lyon, Bron, France.
Caroline DemilyCentre de Référence GénoPsy, Service Hospitalo-Universitaire, CRMR Maladies Rares à Expression Psychiatrique, Centre Hospitalier le Vinatier, Pôle Ouest, Bron, Université Lyon 1, Lyon, France.
Nicolas ChatronService de Génétique, Centre de Référence Anomalies du Développement, Hospices Civils de Lyon, Bron, France.
Audrey LabalmeService de Génétique, Centre de Référence Anomalies du Développement, Hospices Civils de Lyon, Bron, France.
Pierre-Antoine Rollat-FarnierService de Génétique, Centre de Référence Anomalies du Développement, Hospices Civils de Lyon, Bron, France.
Caroline Schluth-BolardService de Génétique, Centre de Référence Anomalies du Développement, Hospices Civils de Lyon, Bron, France.
Brigitte Gilbert-DussardierService de génétique médicale, CHU de Poitiers, and EA 3808, Université de Poitiers, Poitiers, France.
Fabienne GiulianoService de génétique, CHU de Nice, Nice, France.
Renaud TouraineService de génétique clinique, chromosomique et moléculaire, CHU Saint-Etienne, Saint Priez en Jarez, France.
Sylvie TordjmanPôle Hospitalo-Universitaire de Psychiatrie Enfant et Adolescent (PHUPEA), Centre Hospitalier Guillaume Régnier, Université Rennes 1, Rennes, France.
Alain VerloesDépartement de Génétique, APHP-Robert DEBRE University Hospital, USPC University and INSERM UMR1141, Paris, France.
Giuseppe TestaDepartment of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
Damien SanlavilleService de Génétique, Centre de Référence Anomalies du Développement, Hospices Civils de Lyon, Bron, France.
Patrick EderyService de Génétique, Centre de Référence Anomalies du Développement, Hospices Civils de Lyon, Bron, France.
Gaetan LescaService de Génétique, Centre de Référence Anomalies du Développement, Hospices Civils de Lyon, Bron, France.
Massimiliano RossiService de Génétique, Centre de Référence Anomalies du Développement, Hospices Civils de Lyon, Bron, France. massimiliano.rossi01@chu-lyon.fr.ORCID 0000-0002-5797-8152
Université Claude Bernard Lyon 1 · FRHospices Civils de Lyon · FRCentre Hospitalier Universitaire de Nice · FRCentre National de la Recherche Scientifique · FRInserm · FRLaboratoire de Génétique Cellulaire · FRUniversité de Poitiers · FRUniversity of Milan · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Williams Beuren syndrome (WBS) is a multiple malformations/intellectual disability (ID) syndrome caused by 7q11.23 microdeletion and clinically characterized by a typical neurocognitive profile including excessive talkativeness and social disinhibition, often defined as "overfriendliness" and "hyersociability". WBS is generally considered as the polar opposite phenotype to Autism Spectrum Disorder (ASD). Surprisingly, the prevalence of ASD has been reported to be significantly higher in WBS (12%) than in general population (1%). Our study aims to investigate the molecular basis of the peculiar association of ASD and WBS. We performed chromosomal microarray analysis and whole exome sequencing in six patients presenting with WBS and ASD, in order to evaluate the possible presence of chromosomal or gene variants considered as pathogenic.Our study shows that the presence of ASD in the recruited WBS patients is due to i) neither atypically large deletions; ii) nor the presence of pathogenic variants in genes localized in the non-deleted 7q11.23 allele which would unmask recessive conditions; iii) moreover, we did not identify a second, indisputable independent genetic diagnosis, related to pathogenic Copy Number Variations or rare pathogenic exonic variants in known ID/ASD causing genes, although several variants of unknown significance were found. Finally, imprinting effect does not appear to be the only cause of autism in WBS patients, since the deletions occurred in alleles of both maternal and paternal origin.The social disinhibition observed in WBS does not follow common social norms and symptoms overlapping with ASD, such as restricted interests and repetitive behavior, can be observed in "typical" WBS patients: therefore, the terms "overfriendliness" and "hypersociability" appear to be a misleading oversimplification.The etiology of ASD in WBS is likely to be heterogeneous. Further studies on large series of patients are needed to clarify the observed variability in WBS social communication, ranging from excessive talkativeness and social disinhibition to absence of verbal language and social deficit.

Indexed as

AdolescentAdultAutism Spectrum DisorderChildChromosome DeletionDNA Copy Number VariationsExome SequencingFemaleHumansMalePhenotypeWilliams SyndromeYoung Adult7q11.23 microdeletionAutism Spectrum DisorderGTF2IWhole exome sequencingWilliams Beuren syndrome

Identifiers

PMID31151468
PMCPMC6545013
OpenAlexW2947280478

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.